MENU
+Compare
NVO
Stock ticker: NYSE
AS OF
Dec 3 closing price
Price
$47.57
Change
+$0.14 (+0.30%)
Capitalization
210.14B

NVO Novo-Nordisk A/S Forecast, Technical & Fundamental Analysis

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more

NVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NVO with price predictions
Nov 28, 2025

NVO's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for NVO turned positive on November 13, 2025. Looking at past instances where NVO's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NVO's RSI Indicator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on NVO as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVO advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVO entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.994) is normal, around the industry mean (8.915). P/E Ratio (13.098) is within average values for comparable stocks, (23.825). Projected Growth (PEG Ratio) (1.610) is also within normal values, averaging (2.041). Dividend Yield (0.036) settles around the average of (0.026) among similar stocks. P/S Ratio (4.307) is also within normal values, averaging (3.624).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVO is expected to report earnings to rise 34.39% to 93 cents per share on February 04

Novo-Nordisk A/S NVO Stock Earnings Reports
Q4'25
Est.
$0.93
Q3'25
Missed
by $0.09
Q2'25
Est.
$0.93
Q1'25
Beat
by $5.64
Q4'24
Beat
by $5.46
The last earnings report on November 05 showed earnings per share of 69 cents, missing the estimate of 78 cents. With 11.47M shares outstanding, the current market capitalization sits at 210.14B.
A.I.Advisor
published Dividends

NVO paid dividends on August 26, 2025

Novo-Nordisk A/S NVO Stock Dividends
А dividend of $0.58 per share was paid with a record date of August 26, 2025, and an ex-dividend date of August 18, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XTL146.712.50
+1.73%
State Street® SPDR® S&P® Telecom ETF
EAI20.900.08
+0.38%
Entergy Arkansas LLC
VCSH79.710.04
+0.06%
Vanguard Short-Term Corporate Bond ETF
PTEU30.400.01
+0.04%
Pacer Trendpilot™ European ETF
GGN5.08-0.07
-1.36%
GAMCO Global Gold Natural Resources & Income Trust

NVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been closely correlated with NONOF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVO jumps, then NONOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-2.04%
NONOF - NVO
70%
Closely correlated
N/A
TECH - NVO
36%
Loosely correlated
-1.32%
GMAB - NVO
35%
Loosely correlated
+1.05%
MRK - NVO
34%
Loosely correlated
-0.76%
NVS - NVO
34%
Loosely correlated
+2.59%
More

Groups containing NVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-2.04%
Pharmaceuticals
category (377 stocks)
45%
Loosely correlated
+0.67%
Pharmaceuticals: Major
category (61 stocks)
42%
Loosely correlated
+0.20%